Trastuzumab Deruxtecan Ushers in New Treatment Era for HER2-Low Breast Cancer

(MedPage Today) -- CHICAGO -- Patients with HER2-low metastatic breast cancer treated with trastuzumab deruxtecan (Enhertu) achieved significant improvements in survival compared with those treated with chemotherapy alone, according to results...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news